Uptake of ranibizumab but not bevacizumab into uveal melanoma cells correlates with a sustained decline in VEGF-A levels and metastatic activities

Aysegül Tura, Vera E. Pawlik, Martin Rudolf, Justus S. Ernesti, Jan Niklas Stutzer, Salvatore Grisanti, Mahdy Ranjbar*

*Korrespondierende/r Autor/-in für diese Arbeit
2 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Uptake of ranibizumab but not bevacizumab into uveal melanoma cells correlates with a sustained decline in VEGF-A levels and metastatic activities“. Zusammen bilden sie einen einzigartigen Fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience